More than two-thirds of pancreatic cancer patients harboring genetic mutations saw their tumor stop growing or shrink substantially after being switched from intensive chemotherapy to the PARP inhibitor rucaparib as a maintenance therapy.
Forschungsgruppe Quanteneffekte bei Krankheiten (qrdrg.xonl.de)
Copyright © 2023 MEDIZIN.NEWZS.de - Quantum Related Diseases Research Group (QRDRG)